| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Klaus Elenius | Q42645540 |
| Kristiina Iljin | Q108557394 | ||
| P2093 | author name string | Ville Veikkolainen | |
| Maria Sundvall | |||
| Katri Vaparanta | |||
| Kalle Halkilahti | |||
| P433 | issue | 16 | |
| P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
| P304 | page(s) | 2647-2657 | |
| P577 | publication date | 2011-08-15 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | Function of ERBB4 is determined by alternative splicing | |
| P478 | volume | 10 |
| Q49629866 | A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution |
| Q38118935 | Aberrant splicing in neurological diseases. |
| Q62746702 | Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response |
| Q38954270 | Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia. |
| Q91014003 | Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders |
| Q54457600 | CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro. |
| Q40817583 | Calpain-Dependent ErbB4 Cleavage Is Involved in Brain Ischemia-Induced Neuronal Death |
| Q34079890 | Characterization of glial cell models and in vitro manipulation of the neuregulin1/ErbB system |
| Q90699218 | Comprehensive review of targeted therapy for colorectal cancer |
| Q36505841 | Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells |
| Q38219835 | Developmental pathways hijacked by osteosarcoma |
| Q37612459 | Developmental pruning of excitatory synaptic inputs to parvalbumin interneurons in monkey prefrontal cortex. |
| Q36924803 | Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo |
| Q35763919 | Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression |
| Q38971615 | ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy |
| Q37040838 | ERBB4 confers metastatic capacity in Ewing sarcoma |
| Q47974787 | ErbB Receptors and Cancer |
| Q43248887 | ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease |
| Q37745253 | ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation. |
| Q33631943 | ErbB4, a receptor tyrosine kinase, coordinates organization of the seminiferous tubules in the developing testis |
| Q47989436 | Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases. |
| Q59329897 | HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women |
| Q52608458 | HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer. |
| Q38656435 | Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. |
| Q45358927 | Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE. |
| Q34070488 | Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland |
| Q24634266 | Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene |
| Q40980634 | Local delivery of the Neuregulin1 receptor ecto-domain (ecto-ErbB4) has a positive effect on regenerated nerve fiber maturation |
| Q57105786 | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer |
| Q37716882 | Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase |
| Q37529620 | Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase |
| Q37727542 | Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant |
| Q36288449 | Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration |
| Q38104664 | Neuregulin 3 and erbb signalling networks in embryonic mammary gland development. |
| Q41687462 | Neuregulin signaling pathway in smoking behavior |
| Q27022965 | Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines |
| Q36408020 | Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo |
| Q38193084 | Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders |
| Q27853060 | Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer |
| Q35000695 | Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis |
| Q51198669 | Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. |
| Q27670640 | Proteolytic Processing of ErbB4 in Breast Cancer |
| Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
| Q35888647 | Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling |
| Q26830216 | Receptor tyrosine kinases in the nucleus |
| Q38782723 | Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function. |
| Q27001635 | Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer |
| Q37391177 | Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders |
| Q64256021 | Target HER four in breast cancer? |
| Q38890318 | The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness |
| Q34511472 | The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China |
| Q33567012 | The heterogeneous landscape of ALK negative ALCL. |
| Q33977133 | The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer |
| Q34341876 | The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. |
| Q34996222 | The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients |
| Q36042588 | The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation |
Search more.